SCB-1022

· Clover Biopharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SCB-1022, covering 2025-08-08 to 2025-08-08. Get the full timeline:

Most recent: Clinical Trial Update: First-in-human Safety and Immunogenicity Study of SCB-1022 and SCB-1033 in Healthy Older Adults [Phase 1]